(NGVT) Ingevity - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US45688C1071
NGVT EPS (Earnings per Share)
NGVT Revenue
NGVT: Activated Carbon, Specialty Chemicals, Polymers
Ingevity Corporation is a global manufacturer and supplier of high-performance materials and chemicals, operating across three distinct business segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The companys products play a critical role in various industries, including automotive, construction, and industrial manufacturing, with applications in emission control systems, pavement construction, and specialty polymers for coatings and adhesives.
The Performance Materials segment is a key player in the production of activated carbon products, which are used in gasoline vapor emission control systems, as well as in food, water, and beverage purification applications. The Performance Chemicals segment serves the road construction and industrial sectors with a range of products, including pavement preservation technologies and agrochemical dispersants. Meanwhile, the Advanced Polymer Technologies segment produces caprolactone-based specialty polymers used in coatings, resins, and bioplastics.
With a global presence spanning North America, Asia Pacific, Europe, the Middle East, Africa, and South America, Ingevity Corporation has established a diverse customer base, including automotive parts manufacturers, construction companies, and industrial manufacturers. The companys products are sold through a combination of sales representatives, third-party sales representatives, and distributors.
From a technical analysis perspective, Ingevitys stock price has been trending upwards, with the 50-day SMA at $42.29 and the 200-day SMA at $41.02. The current price of $42.01 is near the 52-week high of $50.21, indicating a strong recovery from the 52-week low of $29.88. The ATR of 1.61 represents a 3.83% daily price range, suggesting moderate volatility.
Combining the technical and fundamental data, we can forecast that Ingevity Corporation is poised for growth, driven by its diversified product portfolio and global presence. With a forward P/E ratio of 9.97, the stock appears undervalued relative to its growth prospects. As the company continues to expand its operations and improve its profitability, we can expect the stock price to appreciate, potentially reaching $50 in the near term. However, the negative RoE of -152.32 indicates that the company still faces challenges in terms of profitability, and investors should closely monitor the companys progress in addressing these issues.
Additional Sources for NGVT Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
NGVT Stock Overview
Market Cap in USD | 1,603m |
Sector | Basic Materials |
Industry | Specialty Chemicals |
GiC Sub-Industry | Specialty Chemicals |
IPO / Inception | 2016-05-02 |
NGVT Stock Ratings
Growth Rating | -30.9 |
Fundamental | -35.1 |
Dividend Rating | 0.0 |
Rel. Strength | -3.3 |
Analysts | 4 of 5 |
Fair Price Momentum | 36.24 USD |
Fair Price DCF | 37.03 USD |
NGVT Dividends
Currently no dividends paidNGVT Growth Ratios
Growth Correlation 3m | 66.8% |
Growth Correlation 12m | 2.9% |
Growth Correlation 5y | -72.1% |
CAGR 5y | -3.99% |
CAGR/Max DD 5y | -0.06 |
Sharpe Ratio 12m | 0.32 |
Alpha | -22.02 |
Beta | 1.668 |
Volatility | 44.75% |
Current Volume | 161.2k |
Average Volume 20d | 183.2k |
As of June 26, 2025, the stock is trading at USD 42.17 with a total of 161,157 shares traded.
Over the past week, the price has changed by +1.91%, over one month by -3.61%, over three months by -2.09% and over the past year by -3.43%.
Probably not. Based on ValueRay´s Fundamental Analyses, Ingevity (NYSE:NGVT) is currently (June 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -35.10 and therefor a somewhat negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NGVT is around 36.24 USD . This means that NGVT is currently overvalued and has a potential downside of -14.06%.
Ingevity has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy NGVT.
- Strong Buy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, NGVT Ingevity will be worth about 41.2 in June 2026. The stock is currently trading at 42.17. This means that the stock has a potential downside of -2.3%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 51.8 | 22.7% |
Analysts Target Price | 51.8 | 22.7% |
ValueRay Target Price | 41.2 | -2.3% |